Examining FDA Reauthorization Act Add-On Provisions
On Aug. 18, 2017, President Donald Trump signed into law the Food and Drug Administration Reauthorization Act (FDARA), which previously passed in the Senate by a vote of 94-1,[1] following passage...To view the full article, register now.
Already a subscriber? Click here to view full article